These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 35584975)

  • 1. Impact of cardiac amyloidosis on outcomes of patients hospitalized with heart failure.
    Göbel S; Hobohm L; Desuki A; Gori T; Münzel T; Claudio R; Wenzel P; Keller K
    Eur J Intern Med; 2022 Aug; 102():88-96. PubMed ID: 35584975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Arrhythmias on Hospitalizations in Patients With Cardiac Amyloidosis.
    Thakkar S; Patel HP; Chowdhury M; Patel K; Kumar A; Arora S; Zahid S; Goel M; Barssoum K; Jain V; AbouEzzeddine OF; DeSimone CV; Baibhav B; Rao M; Deshmukh A
    Am J Cardiol; 2021 Mar; 143():125-130. PubMed ID: 33352208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloidosis and 30-Day Outcomes Among Patients With Heart Failure: A Nationwide Readmissions Database Study.
    Arora S; Patil NS; Strassle PD; Qamar A; Vaduganathan M; Fatima A; Mogili K; Garipalli D; Grodin JL; Vavalle JP; Fonarow GC; Bhatt DL; Pandey A
    JACC CardioOncol; 2020 Dec; 2(5):710-718. PubMed ID: 34396285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients with cardiac amyloidosis are at a greater risk of mortality and hospital readmission after acute heart failure.
    Berthelot E; Broussier A; Hittinger L; Donadio C; Rovani X; Salengro E; Megbemado R; Godreuil C; Belmin J; David JP; Genet B; Damy T;
    ESC Heart Fail; 2023 Jun; 10(3):2042-2050. PubMed ID: 37051755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of heart failure in cardiac amyloidosis using an ambulatory diuresis clinic.
    Vaishnav J; Hubbard A; Chasler JE; Lepley D; Cuomo K; Riley S; Menzel K; Fajardo J; Sharma K; Judge DP; Russell SD; Gilotra NA
    Am Heart J; 2021 Mar; 233():122-131. PubMed ID: 33352187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex-specific differences drive temporal trends and outcomes of patients hospitalized for heart failure in Germany.
    Göbel S; Hobohm L; Ostad MA; Lavie CJ; Gori T; Münzel T; Wenzel P; Keller K
    Prog Cardiovasc Dis; 2020; 63(5):591-598. PubMed ID: 32224115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends and Outcomes in Cardiac Arrest Among Heart Failure Admissions.
    Chouairi F; Miller PE; Loriaux DB; Katz JN; Sen S; Ahmad T; Fudim M
    Am J Cardiol; 2023 May; 194():93-101. PubMed ID: 36889986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and Risk Factors of Cardiac Amyloidosis in Heart Failure: A Systematic Review and Meta-Analysis.
    See ASY; Ho JS; Chan MY; Lim YC; Yeo TC; Chai P; Wong RCC; Lin W; Sia CH
    Heart Lung Circ; 2022 Nov; 31(11):1450-1462. PubMed ID: 36137915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Patterns of Coronary Artery Disease in Patients With Heart Failure by Cardiac Amyloidosis Status.
    Beyene SS; Yacob O; Melaku GD; Hideo-Kajita A; Kuku KO; Brathwaite E; Wilson V; Dan K; Kadakkal A; Sheikh F; Mohammed S; Garcia-Garcia HM
    Cardiovasc Revasc Med; 2021 Jun; 27():31-35. PubMed ID: 33008788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of heart failure on COVID-19 patients: An insight from nationwide inpatient sample.
    Manasrah N; Duhan S; Ali S; Atti L; Keisham B; Micho T; Titus A; Pandya KK; Patel NN; Uppal D; Sattar Y; AlJaroudi WA; Alraies MC
    Am J Med Sci; 2024 Jun; 367(6):363-374. PubMed ID: 38417573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and determinants of iron deficiency in cardiac amyloidosis.
    Jobbé-Duval A; Bézard M; Moutereau S; Kharoubi M; Oghina S; Zaroui A; Galat A; Chalard C; Hugon-Vallet E; Lemonnier F; Eyharts D; Poulot E; Fanen P; Funalot B; Molinier-Frenkel V; Audard V; Hittinger L; Delbarre MA; Teiger E; Damy T
    ESC Heart Fail; 2022 Apr; 9(2):1314-1327. PubMed ID: 35128833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends, Associations, and Impact of Atrial Fibrillation in Patients With Light-chain Cardiac Amyloidosis.
    Abe T; Olanipekun T; Khoury M; Egbuche O; Effoe V; Ghali J
    Crit Pathw Cardiol; 2021 Sep; 20(3):168-172. PubMed ID: 33606412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of Cardiac Amyloidosis-Associated Heart Failure Hospitalizations Among Fee-for-Service Medicare Beneficiaries in the United States.
    Gilstrap LG; Dominici F; Wang Y; El-Sady MS; Singh A; Di Carli MF; Falk RH; Dorbala S
    Circ Heart Fail; 2019 Jun; 12(6):e005407. PubMed ID: 31170802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing Rate of Hospital Admissions in Patients With Amyloidosis (from the National Inpatient Sample).
    Sperry BW; Saeed IM; Raza S; Kennedy KF; Hanna M; Spertus JA
    Am J Cardiol; 2019 Dec; 124(11):1765-1769. PubMed ID: 31607373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in the prevalence of malignancy among patients admitted with acute heart failure and associated outcomes: a nationwide population-based study.
    Ram P; Tiu A; Lo KB; Parikh K; Shah M
    Heart Fail Rev; 2019 Nov; 24(6):989-995. PubMed ID: 31175492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hospitalization-based epidemiology of systemic and cardiac amyloidosis in the Veneto Region, Italy.
    De Michieli L; Stoppa G; Sinigiani G; Previato L; Lorenzoni G; Salvalaggio A; Berno T; Perazzolo Marra M; Briani C; Iliceto S; Biggeri A; Catelan D; Cipriani A
    Int J Cardiol; 2024 Apr; 400():131804. PubMed ID: 38262481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal Trends and Sex Differences in Patients With Cardiac Amyloidosis and Heart Failure With Preserved Ejection Fraction: Retrospective Analysis of 22,015 Admissions From the National Inpatient Sample.
    Maraey A; Tarabanis C; Hajduczok AG; Salem M; Said E; Elsharnoby H; Khalil M; Elzanaty A; Brailovsky Y; Alam A
    Curr Probl Cardiol; 2023 Jan; 48(1):101393. PubMed ID: 36100096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of in-hospital hyperglycemia in hospitalized patients with acute heart failure: Results of the IN-HF (Italian Network on Heart Failure) Outcome registry.
    Targher G; Dauriz M; Tavazzi L; Temporelli PL; Lucci D; Urso R; Lecchi G; Bellanti G; Merlo M; Rossi A; Maggioni AP;
    Int J Cardiol; 2016 Jan; 203():587-93. PubMed ID: 26574932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19, Heart Failure Hospitalizations, and Outcomes: A Nationwide Analysis.
    Isath A; Malik A; Bandyopadhyay D; Goel A; Hajra A; Dhand A; Lanier GM; Fonarow GC; Lavie CJ; Gass AL
    Curr Probl Cardiol; 2023 Apr; 48(4):101541. PubMed ID: 36529234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient Characteristics and Outcomes of Type 2 Myocardial Infarction During Heart Failure Hospitalizations in the United States.
    Nazir S; Minhas AMK; Kamat IS; Ariss RW; Moukarbel GV; Gomez JCP; Fedson S; Nair A; Bozkurt B; Jneid H
    Am J Med; 2021 Nov; 134(11):1371-1379.e2. PubMed ID: 34214459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.